Get started
MERCK & CO INCMERCK & CO INCMERCK & CO INC

MERCK & CO INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

MRK trade ideas

Big Pharma MERCK & CO in STILL in serious trouble, its happeningAs per my previous analysis: FUNDAMENTALS: Merck -1.91% & Co seem to be in serious trouble after a 'Big Pharma -2.86% Bombshell' where Federal Judge Beth Labson Freeman of San -0.77% Jose finds Merck -1.91% lied in patent trial to both a business partner ( Gilead Sciences Inc -0.41% ) and lied to the court itself, overturns $200 Million verdict ! (Re: hepatitis C Drug). This seems to be now having a negative effect on this stock, as per analysis back on July 16th 2017 and I am expecting this to continue bearish. Source: LA Times Article here: www.latimes.com Court Document here: assets.documentcloud.org Judge Stated "Merck's misconduct includes... misusing Pharmasset's confidential information..., and lying under oath at deposition and trial" - Federal Judge Beth Labson Freeman. One example of this was "The edvidence examined by Freeman strongly suggests that Merck -1.91% flagrantly manipulated the patent process to gain unfair advantage." - Michael Hiltzik, LA Times. AND "Adding to the temerity of the big drugmaker, it originally sued Gilead for $2 billion before having to settle for $200 million. Now, pending appeal, it won’t get even that much for its patent claims, and its reputation for integrity will carry a value of less than zero." - Michael Hiltzik, LA Times. TECHNICALS: (Daily and Weekly Charts) A Gartley pattern has been confirmed and completed as well as breakout from major structure, providing the start of what seems to be an Elliott wave 2 structure in it's infant stages, after completion of a correction and a failed Wave 5 at the top of the chart, where major resistance is located. This initiated Elliott wave count suggests a long-term bearish trend for the pharma -2.86% company down to significantly low price that would normally be expected. Ketchup, Mustard, Water and Mayo EMAs have all been breached by the price action as well as TDI -0.08% showing hints of continued downward movement. Monthly chart also suggests we are at the start of a Bearish Intermediate Wave 1 which does not look good for the pharmaceutical company. However, that being said, this is a FANTASTIC opportunity to SHORT the absolute crap out of this stock, in my opinion I see quite significant Profit from Shorting this stock on a 3 ~ 6 month term, possibly even longer if the wave count is confirmed as described on my chart. I'm shorting this stock on the breakout of structure, where most likely this will occur on market open with a GAP. In my opinion this will be a huge profit maker as I'm expecting this bearish price action to continue for significantly long period of time. ---------------------------------------------------------------------------------------------------------------------------------------------------------- DISCLAIMER: This chart is for sharing and educational purposes only and is not intended to be a signal service or similar. This chart analysis is only provided as my own opinion, based on my own analysis and comes with absolutely no warranty that this analysis is correct, whatsoever. Do not trade this chart if you do not have your own strategy. Trade only with your own strategy at your own risk. Plan your trade and trade your plan... and IF in doubt, stay out. .....::::: If you like this chart, please click on the THUMBS UP ! :::::..... ----------------------------------------------------------------------------------------------------------------------------------------------------------
NYSE:MRKShort
by UnknownUnicorn661419
Big Pharma MERCK & CO in SERIOUS TROUBLE !FUNDAMENTALS: Merck & Co seem to be in serious trouble after a 'Big Pharma Bombshell' where Federal Judge Beth Labson Freeman of San Jose finds Merck lied in patent trial to both a business partner (Gilead Sciences Inc) and lied to the court itself, overturns $200 Million verdict ! (Re: hepatitis C Drug). Source: LA Times Article here: www.latimes.com Court Document here: assets.documentcloud.org Judge Stated "Merck's misconduct includes... misusing Pharmasset's confidential information..., and lying under oath at deposition and trial" - Federal Judge Beth Labson Freeman. One example of this was "The edvidence examined by Freeman strongly suggests that Merck flagrantly manipulated the patent process to gain unfair advantage." - Michael Hiltzik, LA Times. AND "Adding to the temerity of the big drugmaker, it originally sued Gilead for $2 billion before having to settle for $200 million. Now, pending appeal, it won’t get even that much for its patent claims, and its reputation for integrity will carry a value of less than zero." - Michael Hiltzik, LA Times. TECHNICALS: (Daily and Weekly Charts) A Gartley pattern has been confirmed and completed as well as breakout from major structure, providing the start of what seems to be an Elliott wave 2 structure in it's infant stages, after completion of a correction and a failed Wave 5 at the top of the chart, where major resistance is located. This initiated Elliott wave count suggests a long-term bearish trend for the pharma company down to significantly low price that would normally be expected. Ketchup, Mustard, Water and Mayo EMAs have all been breached by the price action as well as TDI showing hints of continued downward movement. Monthly chart also suggests we are at the start of a Bearish Intermediate Wave 1 which does not look good for the pharmaceutical company. However, that being said, this is a FANTASTIC opportunity to SHORT the absolute crap out of this stock, in my opinion I see quite significant Profit from Shorting this stock on a 3 ~ 6 month term, possibly even longer if the wave count is confirmed as described on my chart. I'm shorting this stock on the breakout of structure, where most likely this will occur on market open with a GAP. In my opinion this will be a huge profit maker as I'm expecting this bearish price action to continue for significantly long period of time. ---------------------------------------------------------------------------------------------------------------------------------------------------------- DISCLAIMER: This chart is for sharing and educational purposes only and is not intended to be a signal service or similar. This chart analysis is only provided as my own opinion, based on my own analysis and comes with absolutely no warranty that this analysis is correct, whatsoever. Do not trade this chart if you do not have your own strategy. Trade only with your own strategy at your own risk. Plan your trade and trade your plan... and IF in doubt, stay out. .....::::: If you like this chart, please click on the THUMBS UP ! :::::..... ----------------------------------------------------------------------------------------------------------------------------------------------------------
NYSE:MRKShort
by UnknownUnicorn661419
MRK 4HR Chart: Gap up set up huge News!Was very excited to chart this one as I trade strictly via mobile with TOS Mobile Trader. What you notice in each outline rectangle is one of my fav setups in which is labeled "CANDLE COMBO" Definition: Candle Combo- Basic bullish candle formation that signals more upside. In which the stock usually continues from closing price or initially gaps up. These combos usually occur right below or at middle kelt or upper kelt MRK still has one more gap to fill thats labeled 65.50. If the stock does gap we should retest 65.25 then 65.29 followed by the fill at 65.50. With this fda fast track news which is HUGE we just might fill the gap. -TheTradingNinja
NYSE:MRKLong
by TheTradingNinja
Bullish Moving Average Cross For MerckOn April 19, 2017, Merck & Co ( NYSE:MRK ) crossed above its 150 daily moving average (DMA). Historically this has occurred 227 times and the stock does not always move up. It has a median gain of 4.139% and maximum gain of 18.194% over the next 16 trading days. When we take a look at other technical indicators, the relative strength index (RSI) is at 40.4843. RSI tends to determine trends, overbought and oversold levels as well as likelihood of price swings. I personally use anything above 75 as overbought and anything under 25 as oversold. The current reading declares the stock is relatively neutral. The true strength index (TSI) is currently -18.4921. The TSI determines overbought/oversold levels and/or current trend. I solely use this as an indicator of trend as overbought and oversold levels vary. The TSI is double smoothed in its calculation and is a great indicator of upward and downward movement. The current reading declares the stock is moving down, but the decline is slowing making a potential reversal to the upside possible. The positive vortex indicator (VI) is at 0.7725 while the negative is at 1.1322. When the positive level is higher than 1 and higher than the negative indicator, the overall price action is moving upward. When the negative level is higher than 1 and higher than the positive indicator, the overall price action is moving downward. The current reading declares the stock is moving down. The stochastic oscillator K value is 24.0888 and D value is 25.7547. This is a cyclical oscillator that is highly accurate and can be used to identify overbought/oversold levels as well as pending reversals and short-term activity. I personally use anything above 80 as overbought and below 20 as oversold. When the K value is higher than the D value, the price action is trending up. When the D value is higher that the K value, price action is trending down. The current reading declares the stock is on the verge is moving up and away from oversold territory. Considering the moving average crossover, RSI, TSI, VI and stochastic levels, the overall direction appears to continue heading up. Based on historical movement compared to current levels and the current position in its macro trend channel, the stock could gain at least 2.12% over the next 16 trading days. On April 18, the stock crossed below the 150 DMA. In the last 10 years when the stock is above the 150 DMA, crosses under for one day before re-crossing above, the stock has always gone up over the next 16 trading days. These occurrences were in July 2009, April 2010, November 2011 (3 times), June 2012, March 2013, February 2015, and January 2017. The stock gained 15.911%, 0.971%, 5.072%, 5.531%, 2.517%, 9.091%, 7.659%, 1.134%, and 5.080% respectively. The median gain was 5.080% during this period.
NYSE:MRKLong
by StockSignaler